e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Precision meets immunology in treatment of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - IgE-FceR1 cross-linking impairs the capacity of plasmacytoid dendritic cells to induce in vitro functional regulatory T cells which can be restored by Omalizumab
J. López-Abente (Madrid, Spain), C. Benito-Villalvilla (Madrid, Spain), X. Jaumont (Basel, Switzerland), P. Pfister (Basel, Switzerland), P. Tassinari (Basel, Switzerland), O. Palomares (Madrid, Spain)
Source:
International Congress 2019 – Precision meets immunology in treatment of airway diseases
Session:
Precision meets immunology in treatment of airway diseases
Session type:
Oral Presentation
Number:
3803
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. López-Abente (Madrid, Spain), C. Benito-Villalvilla (Madrid, Spain), X. Jaumont (Basel, Switzerland), P. Pfister (Basel, Switzerland), P. Tassinari (Basel, Switzerland), O. Palomares (Madrid, Spain). Late Breaking Abstract - IgE-FceR1 cross-linking impairs the capacity of plasmacytoid dendritic cells to induce in vitro functional regulatory T cells which can be restored by Omalizumab. 3803
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Exposure of dendritic cells to biomedical nanoparticles down-regulates their capacity for antigen-specific CD4+ T cell stimulation
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009
Effects of dendritic cells overexpressing Serrate1 on the polarization of CD4+CD25+ T cells and the production of inhibitory cytokines
in vitro
Source: Eur Respir J 2005; 26: Suppl. 49, 25s
Year: 2005
The effect of Immunotherapy on the expression of costimulatory pathway molecules on dendritic cells and T cells in asthmatic mice
Source: Eur Respir J 2003; 22: Suppl. 45, 483s
Year: 2003
Mast cell activation leads to migration of T-cells
in vitro
Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Year: 2007
Human myeloid lung dendritic cells are strong inducers of T cell proliferation compared to plasmacytoid lung dendritic cells
Source: Annual Congress 2005 - Basic mechanisms in asthma and COPD: new insights
Year: 2005
Increased pro-inflammatory regulatory T Cells correlate with the plasticity of T helper cell differentiation in asthma
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4
+
T cell stimulation
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Comprehensive characterisation of T helper cells, cytotoxic T cells and novel invariant T cell phenotypes in human asthma
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Effect of OVA activated tolerogenic mouse bone marrow dendritic cells on the production of IL-17 in vitro
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Surfactant decreases LPS-dependent CD4
+
T cell stimulation by dendritic cells
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009
Activin-A is a critical inducer of human CD4+ICOS+IL-10-secreting regulatory T cells that suppress allergen-driven T cell responses in vitro and experimental asthma in a humanized mouse model in vivo
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
High concentration of antigen induces allergic mice T cells anergy with depressing CD86 expression on antigen-presenting cells
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002
Role of dendritic cells and T-regulatory cells in COPD
Source: Annual Congress 2013 –Immunopathology of COPD: contribution of advancements of new therapeutic agents
Year: 2013
Airway epithelial cells activate anti-viral pathways in human dendritic cells
Source: Annual Congress 2009 - Lung cell biology and immunology
Year: 2009
Induction of enhanced antitumor immunity by fusion of Interleukin-12 gene-modified cancer cells with dendritic cells
Source: Eur Respir J 2003; 22: Suppl. 45, 199s
Year: 2003
Organic dust induces intracellular production of cytokines in monocytes, NK and T cells
in vitro
Source: Eur Respir J 2001; 18: Suppl. 33, 113s
Year: 2001
Microvesicles from human activated dendritic cells are released as a function of danger signals and fuse with resting dendritic cells allowing them to present allo-antigens
Source: Eur Respir J 2006; 28: Suppl. 50, 340s
Year: 2006
CD38 gene-modified dendritic cells inhibit murine asthma development through increasing IL-12 production and promoting Th1 cell differentiation
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept